‹ CCCC latest research

CCCC (C4 Therapeutics, Inc.): every AI call and what happened next

TradeFlare's AI research teams analysed CCCC on 7 market nights between April 14, 2026 and July 15, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

7 calls 5 BUY · 2 HOLD · 0 SELL BUY calls up after 20 trading days: 5 of 5
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
July 15, 2026 BUY $3.81 — / — -1.6% +2.6%
The stock is being held due to negative fundamental analysis and high risk, despite some positive sentiment.
July 14, 2026 BUY $3.92 — / — +0.5% +1.6%
The stock is currently consolidating near resistance with mixed technical signals, and a clear directional bias is not established.
July 13, 2026 HOLD $4.06 — / — -8.7% -7.7%
June 1, 2026 BUY $4.37 — / — -18.0% +6.6%
The current market regime is neutral, and the stock's conflicting team scores and high risk profile necessitate a cautious approach.
April 30, 2026 BUY $2.56 $2.94 / $2.18 +5.3% +54.4%
The market regime is neutral, and the stock lacks a clear catalyst for a directional move.
April 29, 2026 BUY $2.75 $3.05 / $2.34 +14.4% +43.0%
Waiting for a clearer signal in a neutral market.
April 14, 2026 HOLD $2.76 $3.06 / $2.60 +13.0% +14.9%
The technical analysis suggests a potential short-term bullish move towards $3.06, but the overall trend is unclear, warranting a short-term hold.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.